Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Classifica tra le azioni #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Prezzo delle azioni
$0.88012714
Capitalizzazione di mercato
$439.58M
Variazione (1 giorno)
-4.01%
Variazione (1 anno)
1,130.75%
Paese
FR
Scambia Valerio Therapeutics S.A. (ALVIO)

Categoria

Storico del prezzo dell'azione per Valerio Therapeutics S.A. (ALVIO)
Prezzo di chiusura più alto: $0.91 il 2026-08-01

Prezzo di chiusura più basso: $0.28 il 2023-06-01
Storico del prezzo dell'azione di Valerio Therapeutics S.A. dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 53.06%
2025 116.87%
2024 -58.47%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -12.20%
AU
$138.80 476.17%
US
$749.90 5.10%
CH